CLN7 gene therapy (Neurogene)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCLN7 gene therapy (Neurogene)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuronal Ceroid-Lipofuscinoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurogene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurogene Inc
Active IndicationsN/A
Inactive IndicationsNeuronal Ceroid-Lipofuscinoses

Other Information

ATC CodeN/A
Related LinksN/A